Prevalence of cervical human papillomavirus in Mexico, 2010-2017: analysis of 2.7 million women.

Erika Hurtado-SalgadoEduardo Ortiz-PanozoJorge SalmerónRufino Luna-GordilloBetania Allen-LeighNenetzen Saavedra-LaraEduardo L FrancoEduardo Lazcano-Ponce

Published in: Cancer causes & control : CCC (2022)

Understanding the distribution of HPV prevalence has value as evidence for developing policy in order to improve cervical cancer screening strategies. These results will constitute evidence to allow decision makers to better choose where to focus those resources that they do have.

Keyphrases

cervical cancer screening
risk factors
public health
healthcare
mental health
polycystic ovary syndrome
decision making
pregnant women
breast cancer risk